Warning Letter — Nutratech, LLC
The FDA issued a warning letter to Nutratech, LLC following an inspection by the Human Foods Program that identified significant violations of regulatory requirements.
This notice affects Nutratech, LLC and personnel involved in the manufacturing, packaging, labeling, or holding of human food and dietary supplement products.
This enforcement action underscores the FDA's continued focus on dietary supplement manufacturing standards under the Human Foods Program. The issuance of a warning letter suggests that previously identified deficiencies were not sufficiently addressed or represent a significant risk to product integrity, requiring formalized corrective actions to avoid further escalation such as seizure or injunction.
Quality units should verify that all manufacturing processes are supported by documented specifications and that final products undergo verified testing protocols. Firms should review their supplier qualification programs and internal audit schedules to identify gaps in Human Foods Program compliance prior to FDA inspection.
FDA Warning Letter issued to: Nutratech, LLC. 06/04/2026 — Human Foods Program. Source: https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/nutratech-llc-723021-06042026
Open in openFDA / FDA.gov